about
Epidemiology, risk factors, and lifestyle modifications for goutSociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adultsTrends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES).Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease.Association of connexin gene polymorphism with essential hypertension in Kazak and Han Chinese in Xinjiang, China.QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria.Spontaneous renal artery dissection: three cases and clinical algorithms.Molecular mechanism of vitamin D in the cardiovascular systemControlled-release carvedilol in the management of systemic hypertension and myocardial dysfunctionRisk of endometrial cancer in relation to medical conditions and medication use.Role of carvedilol controlled-release in cardiovascular disease.Aldosterone synthase inhibitors in hypertension: current status and future possibilities.Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving antihypertensive treatment.beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.Evaluation of left ventricular hypertrophy in patients requiring permanent pacing.Changes in thickness of central macula and retinal nerve fibre layer in severe hypertensive retinopathy: a 1-year longitudinal study.Early autonomic malfunction in normotensive individuals with a genetic predisposition to essential hypertension.Practical strategies for cardiac disease prevention. Basic steps to ensure better heart health.
P2860
Q28199023-D09BC1D1-DE10-4E0C-90DA-885787452DACQ33277968-17221C2B-3480-4799-8F70-D0F672F30D37Q33859246-34A2EBA4-D465-459E-9F88-4DCA91806FEDQ33903371-0E9FF59F-434E-4051-AFD1-00130197CF84Q34231858-D05F1CBE-0C14-4F6E-A921-392DEEDD33E7Q36342760-459A0FDB-DF81-46ED-B763-BBC16B526B51Q36449924-2F4B0F6E-AD2D-408A-A26A-34CC6E2CAA03Q36482503-74C7A4C7-E538-4F71-B22F-ED7175136897Q36821166-AF5374F8-8312-4394-AF05-DDA68B8F85F7Q37145670-E8806358-0652-46E6-9879-EDB62F683168Q37390358-A52EFD5A-4C47-42D9-8024-2DCDE593923EQ37472042-3BF693ED-6817-4405-B5DA-1F84E8E15A07Q37594892-3E1D5257-4F89-46D4-BBC5-32FABEB870F9Q44285172-BDCB0594-A777-4E16-8D37-C97635B5AD8EQ45332974-E21EF26E-345B-4ADF-846C-BEB225AD17B1Q46077233-E855A185-F0AB-4C27-AC1E-258CEB95DA8CQ48247774-20EFD80B-57A9-4EBD-A644-5D1B2616F2FAQ51667938-E65EF513-DDC2-4C5F-AC15-2C13BF304F31Q51699086-357E9D4F-17B1-4769-9F76-B8E1443B0080
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Initial treatment of hypertension.
@ast
Initial treatment of hypertension.
@en
type
label
Initial treatment of hypertension.
@ast
Initial treatment of hypertension.
@en
prefLabel
Initial treatment of hypertension.
@ast
Initial treatment of hypertension.
@en
P356
P1476
Initial treatment of hypertension.
@en
P2093
Phyllis August
P304
P356
10.1056/NEJMCP010357
P407
P577
2003-02-01T00:00:00Z